Abstract
Iron is crucial for many biochemical reactions involved in the growth and multiplication of the malaria parasite Plasmodium falciparum. There are many reports indicating that the iron chelators have antimalarial activity in vitro, in vivo and in human studies. However, these compounds suffer from a number of serious problems such as limited membrane permeability, short half-life and require long subcutaneous infusions. To circumvent these drawbacks we have designed a new class of iron chelators, wherein EDTA is tethered to 4-aminoquinoline. Here 4-aminoquinoline scaffold is used as a carrier to penetrate biological membrane and facilitate targetting the compounds to acidic food vacuole of the parasite. This study describes the synthesis of novel iron chelators and their in vitro antimalarial activity against P. falciparum strain of NF-54. The calculated LogP values of these compounds suggest the importance of lipophilicity for the antimalarial activity. The EDTA esters are more active than the corresponding acids. The biophysical studies suggest that these compounds may inhibit the parasite growth by iron chelation mechanism.
Keywords: antimalarial agents, 4-aminoquinoline, Iron chelator
Medicinal Chemistry
Title: Design, Synthesis and Antimalarial Activity of a New Class of Iron Chelators
Volume: 2 Issue: 2
Author(s): Kumkum Srivastava, S. B. Katti, Sunil K. Puri, W. Haq and V. R. Solomon
Affiliation:
Keywords: antimalarial agents, 4-aminoquinoline, Iron chelator
Abstract: Iron is crucial for many biochemical reactions involved in the growth and multiplication of the malaria parasite Plasmodium falciparum. There are many reports indicating that the iron chelators have antimalarial activity in vitro, in vivo and in human studies. However, these compounds suffer from a number of serious problems such as limited membrane permeability, short half-life and require long subcutaneous infusions. To circumvent these drawbacks we have designed a new class of iron chelators, wherein EDTA is tethered to 4-aminoquinoline. Here 4-aminoquinoline scaffold is used as a carrier to penetrate biological membrane and facilitate targetting the compounds to acidic food vacuole of the parasite. This study describes the synthesis of novel iron chelators and their in vitro antimalarial activity against P. falciparum strain of NF-54. The calculated LogP values of these compounds suggest the importance of lipophilicity for the antimalarial activity. The EDTA esters are more active than the corresponding acids. The biophysical studies suggest that these compounds may inhibit the parasite growth by iron chelation mechanism.
Export Options
About this article
Cite this article as:
Srivastava Kumkum, Katti B. S., Puri K. Sunil, Haq W. and Solomon R. V., Design, Synthesis and Antimalarial Activity of a New Class of Iron Chelators, Medicinal Chemistry 2006; 2 (2) . https://dx.doi.org/10.2174/157340606776056179
DOI https://dx.doi.org/10.2174/157340606776056179 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
ACAT1 as a Therapeutic Target and its Genetic Relationship with Alzheimer's Disease
Current Alzheimer Research Selection of Reprogramming Factors of Induced Pluripotent Stem Cells Based on the Protein Interaction Network and Functional Profiles
Protein & Peptide Letters Cardiotonic Steroids in Adaptation to Dietary Salt Intake
Current Clinical Pharmacology Antiangiogenic Therapeutic Approaches in Multiple Myeloma
Current Cancer Drug Targets Clinical Pharmacology of Paliperidone Palmitate A Parenteral Long-Acting Formulation for the Treatment of Schizophrenia
Reviews on Recent Clinical Trials Islet Cell Transplantation
Current Molecular Medicine Quinolones: Action and Resistance Updated
Current Topics in Medicinal Chemistry Neuropharmacological Actions of Metformin in Stroke
Current Neuropharmacology Effects of Cholinesterase Inhibitors on the Activities and Protein Levels of Cholinesterases in the Cerebrospinal Fluid of Patients with Alzheimers Disease: A Review of Recent Clinical Studies
Current Alzheimer Research The GABA Shunt: An Attractive and Potential Therapeutic Target in the Treatment of Epileptic Disorders
Current Drug Metabolism Hypoxic Regulation of Metastasis via Hypoxia-Inducible Factors
Current Molecular Medicine Use of Thiazolidinediones and Risk of Bladder Cancer: Disease or Drugs?
Current Drug Safety New Imaging Tracers for the Infected Diabetic Foot (Nuclear and Optical Imaging)
Current Pharmaceutical Design Genome Analysis of Food Grade Lactic Acid-Producing Bacteria: From Basics to Applications
Current Genomics Rev-Dependent Indicator T Cell Line
Current HIV Research Viral Product Trafficking to Mitochondria, Mechanisms and Roles in Pathogenesis
Infectious Disorders - Drug Targets The Coronary Collateral Circulation in Man
Current Cardiology Reviews Improving Health Care for Children with Chronic Conditions: Toward a “Wholistic” Approach
Current Pediatric Reviews Analysis of Various Phytoconstituents Derived from <i>Tinospora cordifolia</i> (Willd.) Miers as Potential α-amylase and α-glucosidase Inhibitors for the Treatment of Type 2 Diabetes Mellitus using Computational Approaches
Current Bioactive Compounds Pharmacotherapy & Surgical Interventions Available for Obesity Management and Importance of Pancreatic Lipase Inhibitory Phytomolecules as Safer Anti-Obesity Therapeutics
Mini-Reviews in Medicinal Chemistry